Published 1998 | Version v1
Miscellaneous

Radiolanthanides as radiopharmaceuticals - current and potential applications in nuclear medicine

Creators

  • 1. Australian Nuclear Science and Technology Organisation, Menai, NSW (Australia). Radiopharmaceuticals Division

Description

Full text: The purpose of this lecture is to present the current and potential application for radiolanthanide as diagnostic and therapeutic agents in diagnosis and therapy for radiopharmaceuticals. In particular these elements offer an opportunity for new and more effective therapeutic aids, however it is critical that the method of delivery is chosen carefully so that the full potential is achieved. The choice of the appropriate chemistry is key to achieving this goal. This talk will illustrated some recent approached and also suggest some future areas worthy of research

Part of:
Rare earths'98. The international rare earths conference, including radio lanthanides in nuclear medicine therapy. Programme and abstracts

Additional details

Publishing Information

Imprint Title
Rare earths'98. The international rare earths conference, including radio lanthanides in nuclear medicine therapy. New technologies for the 21st century. Programme and abstracts
Imprint Pagination
125 p.
Journal Page Range
p. 65

Conference

Title
Rare earths'98. New technologies for the 21st Century
Dates
25-30 Oct 1998
Place
Fremantle, WA (Australia)

INIS

Country of Publication
Australia
Country of Input or Organization
Australia
INIS RN
32044188
Subject category
S62: RADIOLOGY AND NUCLEAR MEDICINE;
Resource subtype / Literary indicator
Conference, Non-conventional Literature
Descriptors DEI
DIAGNOSTIC USES; NUCLEAR MEDICINE; RADIOPHARMACEUTICALS; RARE EARTH COMPOUNDS; THERAPEUTIC USES
Descriptors DEC
DRUGS; LABELLED COMPOUNDS; MATERIALS; MEDICINE; RADIOACTIVE MATERIALS; USES

Optional Information

Notes
This record replaces 31022488 Imprint:The full text of the papers presented at the conference could be found in Materials Science Forum (1999), Vols. 315-317